Tharimmune Statistics
Total Valuation
Tharimmune has a market cap or net worth of $3.72 million. The enterprise value is -$1.06 million.
| Market Cap | 3.72M |
| Enterprise Value | -1.06M |
Important Dates
The last earnings date was Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Tharimmune has 1.49 million shares outstanding. The number of shares has increased by 2,357.50% in one year.
| Current Share Class | 1.49M |
| Shares Outstanding | 1.49M |
| Shares Change (YoY) | +2,357.50% |
| Shares Change (QoQ) | +60.82% |
| Owned by Insiders (%) | 1.79% |
| Owned by Institutions (%) | 1.97% |
| Float | 1.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.35
| Current Ratio | 2.35 |
| Quick Ratio | 2.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -837.16 |
Financial Efficiency
Return on equity (ROE) is -454.53% and return on invested capital (ROIC) is -291.07%.
| Return on Equity (ROE) | -454.53% |
| Return on Assets (ROA) | -165.08% |
| Return on Capital (ROIC) | -291.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.62M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.83% in the last 52 weeks. The beta is 1.44, so Tharimmune's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | -96.83% |
| 50-Day Moving Average | 2.42 |
| 200-Day Moving Average | 4.08 |
| Relative Strength Index (RSI) | 52.80 |
| Average Volume (20 Days) | 3,714,781 |
Short Selling Information
The latest short interest is 496,869, so 33.44% of the outstanding shares have been sold short.
| Short Interest | 496,869 |
| Short Previous Month | 17,697 |
| Short % of Shares Out | 33.44% |
| Short % of Float | 34.05% |
| Short Ratio (days to cover) | 0.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.12M |
| Pretax Income | -8.88M |
| Net Income | -10.85M |
| EBITDA | n/a |
| EBIT | -11.12M |
| Earnings Per Share (EPS) | -$11.95 |
Balance Sheet
| Cash & Cash Equivalents | 4.77M |
| Total Debt | n/a |
| Net Cash | 4.77M |
| Net Cash Per Share | $3.21 |
| Equity (Book Value) | 3.02M |
| Book Value Per Share | 2.35 |
| Working Capital | 3.02M |
Cash Flow
| Operating Cash Flow | -9.28M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.28M |
| FCF Per Share | -$6.25 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Tharimmune does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,357.50% |
| Shareholder Yield | -2,357.50% |
| Earnings Yield | -292.07% |
| FCF Yield | -249.89% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 28, 2024. It was a reverse split with a ratio of 0.0666667:1.
| Last Split Date | May 28, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0666667:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |